Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
Sodium Hydroxide → Bupivacaine (USAN:INN:BAN)
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | Sodium Hydroxide | HCID 14798 | — |
| 반응물 | Bupivacaine Hydrochloride | HCID 64737 | — |
| 용매 | Water | HCID 962 | — |
| 생성물 | Bupivacaine (USAN:INN:BAN) | HCID 2474 | — |
반응 단계
Bupivacaine hydrochloride (Sigma-Aldrich Corporation, St. Louis, Mo.) was dissolved in de-ionized (DI) water at a concentration of 40 mg/ml (saturation). A calculated amount of sodium hydroxide (1 N solution) was added to the solution and the pH of the final mixtures was adjusted to 10 to precipitate the BP bate. The precipitated product was filtered, and further washed with DI water for at least three times. The precipitated product was dried at approximately 40° C. in vacuum for 24 h.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US08278330B2 |
| 출처 데이터셋 | uspto-grants-2012_10 |
| ORD ID | ord-bbe0ae0487d0453db13663838e0d921d |
| 출처 메모 | uspto-grants-2012_10 |